Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
neuromodulation
MedTech
SetPoint nets $140M following FDA neuromod approval in RA
Shortly after an FDA green light, SetPoint scored $140 million in funding to juice the roll out of its neuromod implant for rheumatoid arthritis.
Conor Hale
Aug 11, 2025 11:30am
Salvia BioElectronics nets $60M for migraine neuromod implant
May 29, 2025 11:00am
ElectroCore buys NeuroMetrix and its Quell fibromyalgia wearable
Dec 20, 2024 9:15am
ShiraTronics nets $66M for neuromod implant for chronic migraine
Oct 9, 2024 11:00am
Jury rules for Axonics in Medtronic’s neurostim patent lawsuit
Sep 19, 2024 12:30pm
Medtronic details study of adaptive neurostim in Parkinson’s
Sep 18, 2024 12:15pm
